{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:24Z","timestamp":1790268624703,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.numecd.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T22:00:44Z","timestamp":1429912844000},"page":"734-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"25","author":[{"given":"L.","family":"Pacifico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Versacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-8745","authenticated-orcid":false,"given":"C.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2015.04.003_bib1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.pcl.2011.09.005","article-title":"Advances in pediatric nonalcoholic fatty liver disease","volume":"58","author":"Mencin","year":"2011","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.numecd.2015.04.003_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc10-0284","article-title":"Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents","volume":"33","author":"D'Adamo","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2015.04.003_bib3","first-page":"9055","article-title":"Nonalcoholic fatty liver disease and the heart in children and adolescents","volume":"20","author":"Pacifico","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2015.04.003_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2015.04.003_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.107.739920","article-title":"Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease","volume":"118","author":"Schwimmer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.04.003_bib6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.23890","article-title":"Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease","volume":"52","author":"Pacifico","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.21983","article-title":"Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver","volume":"47","author":"Perseghin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.numecd.2015.04.003_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26610","article-title":"Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease","volume":"59","author":"Pacifico","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13105-013-0265-4","article-title":"Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence","volume":"69","author":"Lorente-Cebri\u00e1n","year":"2013","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.numecd.2015.04.003_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/1389557514666141013125101","article-title":"Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome","volume":"14","author":"Pacifico","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.numecd.2015.04.003_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2015.04.003_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: results from the *WELCOME study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomized controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.numecd.2015.04.003_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.numecd.2012.10.010","article-title":"Docosahexaenoic acid for the treatment of fatty liver: randomized controlled trial in children","volume":"23","author":"Nobili","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2015.04.003_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0029665111000061","article-title":"The differential effects of EPA and DHA on cardiovascular risk factors","volume":"70","author":"Cottin","year":"2011","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.numecd.2015.04.003_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2015.04.003_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.numecd.2012.08.003","article-title":"Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease","volume":"23","author":"Pacifico","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2015.04.003_bib19","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3748\/wjg.v17.i25.3012","article-title":"T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease","volume":"17","author":"Pacifico","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2015.04.003_bib20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ab.2003.12.016","article-title":"A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies","volume":"326","author":"Marangoni","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.numecd.2015.04.003_bib23","doi-asserted-by":"crossref","first-page":"e88005","DOI":"10.1371\/journal.pone.0088005","article-title":"Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease","volume":"9","author":"Nobili","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2015.04.003_bib24","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1572-0241.2007.01520.x","article-title":"Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD)","volume":"102","author":"Mishra","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.numecd.2015.04.003_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2015.04.003_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/aje\/152.12.1179","article-title":"Utility of different measures of body fat distribution in children and adolescents","volume":"152","author":"Daniels","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2015.04.003_bib27","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2015.04.003_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","article-title":"Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.numecd.2015.04.003_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/oby.20624","article-title":"Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects","volume":"22","author":"Iacobellis","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.numecd.2015.04.003_bib30","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1210\/jc.2006-0584","article-title":"Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels","volume":"91","author":"Kankaanp\u00e4\u00e4","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2015.04.003_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cvr\/cvn310","article-title":"Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload induced cardiac dysfunction","volume":"81","author":"Duda","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2015.04.003_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1472-8206.2010.00839.x","article-title":"Reduced cardiac remodelling and prevention of glutathione deficiency after omega-3 supplementation in chronic heart failure","volume":"25","author":"Fang","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.numecd.2015.04.003_bib33","doi-asserted-by":"crossref","unstructured":"Halade GV, Williams PJ, Lindsey ML, Fernandes G. Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice. Pharmacol Res 2011; 63: 300\u20137.","DOI":"10.1016\/j.phrs.2010.12.012"},{"key":"10.1016\/j.numecd.2015.04.003_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T02:53:59Z","timestamp":1537671239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0939475315001039"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2015.04.003","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}